The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
The Diagnosis and Treatment of Age-Related Macular Degeneration
Open accessAbstract
BACKGROUND: Age-related macular degeneration (AMD) is thought to cause approximately 9% of all cases of blindness worldwide. In Germany, half of all cases of blindness and high-grade visual impairment are due to AMD. In this review, the main risk factors, clinical manifestations, and treatments of this disease are presented. METHODS: This review is based on pertinent publications retrieved by a selective search in PubMed for original articles and reviews, as well as on current position statements by the relevant specialty societies. RESULTS: AMD is subdivided into early, intermediate, and late stages. The early stage is often asymptomatic; patients in the other two stages often have distorted vision or central visual field defects. The main risk factors are age, genetic predisposition, and nicotine consumption. The number of persons with early AMD in Germany rose from 5.7 million in 2002 to ca. 7 million in 2017. Late AMD is subdivided into the dry late form of the disease, for which there is no treatment at present, and the exudative late form, which can be treated with the intravitreal injection of VEGF inhibitors. CONCLUSION: More research is needed on the dry late form of AMD in particular, which is currently untreatable. The treatment of the exudative late form with VEGF inhibitors is labor-intensive and requires a close collaboration of the patient, the ophthalmologist, and the primary care physician.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C.-Y., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,331
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669 · cited 1×
“Multiple clinical trials have shown that most patients require ca. 7–8 injections in the first year of treatment to control exudative AMD effectively (37, 38), with fewer injections generally being needed in later years.”
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Clinical Classification of Age-related Macular Degeneration
Ferris, F. L., Wilkinson, C. P., Bird, A., Chakravarthy, U., Chew, E., Csaky, K., & Sadda, S. R. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.10.036 · Cited by 1,863
Rosenfeld, P. J., Moshfeghi, A. A., & Puliafito, C. A. (2005) · Ophthalmic Surgery, Lasers and Imaging Retina · doi:10.3928/1542-8877-20050701-14 · Cited by 904
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
Chakravarthy, U., Wong, T. Y., Fletcher, A., Piault, E., Evans, C., Zlateva, G., Buggage, R., Pleil, A., & Mitchell, P. (2010) · BMC Ophthalmology · doi:10.1186/1471-2415-10-31 · Cited by 842
Rivera, A., Fisher, S. A., Fritsche, L. G., Keilhauer, C. N., Lichtner, P., Meitinger, T., & Weber, B. H. F. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi353 · Cited by 788
Prevalence of Age-Related Macular Degeneration in Europe
Colijn, J. M., Buitendijk, G. H. S., Prokofyeva, E., Alves, D., Cachulo, M. L., Khawaja, A. P., Cougnard-Gregoire, A., Merle, B. M. J., Korb, C., Erke, M. G., et al. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.05.035 · Cited by 486
Pennington, K. L., & DeAngelis, M. M. (2016) · Eye and Vision · doi:10.1186/s40662-016-0063-5 · Cited by 480
Kanda, A., Chen, W., Othman, M., Branham, K. E. H., Brooks, M., Khanna, R., He, S., Lyons, R., Abecasis, G. R., & Swaroop, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703933104 · Cited by 441
Li, J. Q., Welchowski, T., Schmid, M., Mauschitz, M. M., Holz, F. G., & Finger, R. P. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2019-314422 · Cited by 381
Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010
Bloch, S. B., Larsen, M., & Munch, I. C. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.10.016 · Cited by 377
Holz, F. G., Sadda, S. R., Busbee, B., Chew, E. Y., Mitchell, P., Tufail, A., Brittain, C., Ferrara, D., Gray, S., Honigberg, L., et al. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.1544 · Cited by 354
Bourne, R. R. A., Jonas, J. B., Flaxman, S. R., Keeffe, J., Leasher, J., Naidoo, K., Parodi, M. B., Pesudovs, K., Price, H., White, R. A., et al. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304033 · Cited by 341
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
Tolentino, M. (2011) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2010.08.006 · Cited by 304
Spraul, C. W., Lang, G. E., Grossniklaus, H. E., & Lang, G. K. (1999) · Survey of Ophthalmology · doi:10.1016/s0039-6257(99)00086-7 · Cited by 259
A new perspective on lipid research in age-related macular degeneration
van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247
Cigarette Smoking and Age-Related Macular Degeneration in the EUREYE Study
Chakravarthy, U., Augood, C., Bentham, G. C., de Jong, P. T. V. M., Rahu, M., Seland, J., Soubrane, G., Tomazzoli, L., Topouzis, F., Vingerling, J. R., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.09.022 · Cited by 230 · cited 2×
“The main modifiable risk factor is smoking: smokers have an odds ratio of 2.6 to 4.8 for the emergence of AMD, compared to non-smokers (16).”
InfluentialSmoking and Age-Related Macular Degeneration: Review and Update
Velilla, S., García-Medina, J. J., García-Layana, A., Dolz-Marco, R., Pons-Vázquez, S., Pinazo-Durán, M. D., Gómez-Ulla, F., Arévalo, J. F., Díaz-Llopis, M., & Gallego-Pinazo, R. (2013) · Journal of Ophthalmology · doi:10.1155/2013/895147 · Cited by 221
Progression of Geographic Atrophy in Age-related Macular Degeneration
Keenan, T. D., Agrón, E., Domalpally, A., Clemons, T. E., van Asten, F., Wong, W. T., Danis, R. G., Sadda, S., Rosenfeld, P. J., Klein, M. L., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.05.028 · Cited by 219
Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration
Guymer, R. H., Wu, Z., Hodgson, L. A. B., Caruso, E., Brassington, K. H., Tindill, N., Aung, K. Z., McGuinness, M. B., Fletcher, E. L., Chen, F. K., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.09.015 · Cited by 208
Mediterranean Diet and Incidence of Advanced Age-Related Macular Degeneration
Merle, B. M. J., Colijn, J. M., Cougnard-Grégoire, A., de Koning-Backus, A. P. M., Delyfer, M.-N., Kiefte-de Jong, J. C., Meester-Smoor, M., Féart, C., Verzijden, T., Samieri, C., et al. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.08.006 · Cited by 169
Wecker, T., Ehlken, C., Bühler, A., Lange, C., Agostini, H., Böhringer, D., & Stahl, A. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-308668 · Cited by 162
Self-citationCurcio, C. A. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24883 · Cited by 137
Holz, F. G., Tadayoni, R., Beatty, S., Berger, A. R., Cereda, M. G., Hykin, P. G., Staurenghi, G., Wittrup-Jensen, K., Altemark, A., Nilsson, J., et al. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-308166 · Cited by 127
Meyer, C. H., Michels, S., Rodrigues, E. B., Hager, A., Mennel, S., Schmidt, J. C., Helb, H. –., & Farah, M. E. (2010) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.02064.x · Cited by 124
Merani, R., & Hunyor, A. P. (2015) · International Journal of Retina and Vitreous · doi:10.1186/s40942-015-0010-y · Cited by 111
Chandra, S., Arpa, C., Menon, D., Khalid, H., HAMILTON, R. D., Nicholson, L., Pal, B., Fasolo, S., Hykin, P. G., Keane, P. A., et al. (2020) · Eye · doi:10.1038/s41433-020-0764-9 · Cited by 94
Korb, C. A., Kottler, U. B., Wolfram, C., Höhn, R., Schulz, A., Zwiener, I., Wild, P. S., Pfeiffer, N., & Mirshahi, A. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2591-9 · Cited by 80
Joachim, N., Colijn, J. M., Kifley, A., Lee, K. E., Buitendijk, G. H. S., Klein, R., Myers, C. E., Meuer, S. M., Tan, A. G., Holliday, E. G., et al. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-309729 · Cited by 74
Metabolomics and Age-Related Macular Degeneration
Brown, C. N., Green, B., Thompson, R., den Hollander, A. I., & Lengyel, I. (2018) · Metabolites · doi:10.3390/metabo9010004 · Cited by 71
Blindness and Visual Impairment in Germany
Finger, R. P., Bertram, B., Wolfram, C., & Holz, F. G. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0484 · Cited by 64
Wilde, C., Poostchi, A., Mehta, R. L., MacNab, H. K., Hillman, J. G., Vernon, S. A., & Amoaku, W. M. K. (2017) · Eye · doi:10.1038/eye.2017.30 · Cited by 56
Brandl, C., Zimmermann, M. E., Günther, F., Barth, T., Olden, M., Schelter, S. C., Kronenberg, F., Loss, J., Küchenhoff, H., Helbig, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26629-5 · Cited by 55
Wecker, T., Grundel, B., Reichl, S., Stech, M., Lange, C., Agostini, H. T., Böhringer, D., & Stahl, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-38934-8 · Cited by 54
Self-citationBrandl, C., Breinlich, V., Stark, K. J., Enzinger, S., Aßenmacher, M., Olden, M., Graßmann, F., Graw, J., Heier, M., Peters, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167181 · Cited by 45
Aktuelle Stellungnahme der Retinologischen Gesellschaft, Gesellschaft, D. D. O., & und des Berufsverbands der Augenärzte Deutschlands e., V. (2012) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/s-0031-1299392 · Cited by 38
Yoo, T. K., Kim, S. H., Kwak, J. J., Kim, H. K., & Rim, T. H. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-24059 · Cited by 35
Evans, J. R., & Lawrenson, J. G. (2014) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12142 · Cited by 31
Epidemiologie hochgradiger Sehbehinderungen und Blindheit älterer Menschen in Deutschland
Mauschitz, M. M., Li, J. Q., Larsen, P. P., Köberlein–Neu, J., Holz, F. G., Breteler, M. M. B., & Finger, R. P. (2019) · Der Ophthalmologe · doi:10.1007/s00347-019-0853-y · Cited by 29
Augenheilkunde 2019 – Wo stehen wir?
Schuster, A. K.-G., Wolfram, C., Pfeiffer, N., & Finger, R. P. (2019) · Der Ophthalmologe · doi:10.1007/s00347-019-0894-2 · Cited by 28
Determination of a gene and environment risk model for age-related macular degeneration
Gibson, J., Cree, A. J., Collins, A. R., Lotery, A. J., & Ennis, S. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2010.182568 · Cited by 27
Lee, S., Song, S. J., & Yu, H. G. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.5.769 · Cited by 25
Gesellschaft, D. O. (2015) · Der Ophthalmologe · doi:10.1007/s00347-014-3222-x · Cited by 24
DOG) German Society of Ophthalmology (Deutsche Ophthalmologische Gesellschaft, & RG) German Retina Society (Retinologische Gesellschaft e. V. (2019) · Der Ophthalmologe · doi:10.1007/s00347-019-0889-z · Cited by 2
Gesellschaft, D. O. (2015) · Der Ophthalmologe · doi:10.1007/s00347-014-3220-z · Cited by 1
Metadata
- Authors
- Stahl, A.
- Venue
- Deutsches Ärzteblatt international
- Publisher
- Deutscher Arzte-Verlag GmbH
- Published
- 2020-07-20
- Volume
- 117
- Issue
- 29-30
- Pages
- 513-520
- ISSN
- 1866-0452 (ISSN-L)
- OpenAlex
- W3040833439
- Cited by
- 270
- References
- 52
- FWCI
- 19.15
- Type
- journal article
- Language
- de
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.